Genzyme (GENZ) CEO Dumps 200K Shares As Company Deals With Manufacturing Issues

November 25, 2009 11:16 AM EST Send to a Friend
Genzyme Corp. (Nasdaq: GENZ) Chairman/CEO, Henri A. Termeer, disclosed the sale of 200,000 shares on 11/523 at $50.47 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login